COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

PET imaging reveals long-term heart and lung damage from COVID-19
New data highlight the long-lasting effects of the coronavirus, revealing changes that are not detectable by standard medical assessments.
HHS, NIH announce new ‘universal’ vaccine standard for broad-spectrum protection
Currently in development, the “Generation Gold Standard” platform utilizes inert whole viruses to combat more strains of common illnesses, such as COVID and the flu. It’s on track for FDA approval in 2029.
HHS sued over RFK’s $11B cuts to infectious disease control
The Department of Health and Human Services is refusing to allocate funds meant to support state and local healthcare initiatives, as the money stemmed from now-defunct COVID-19 control efforts. A coalition of municipalities is suing to lift the block.
Owner of home healthcare company gets 14 months for defrauding COVID programs
Nakita Cannady, 49, was also convicted of defrauding Cigna to the tune of $194,000, billing the insurer for patient care hours her providers never filled.
Deaths after TAVR are on the rise: Is the pandemic to blame or should cardiologists be concerned?
COVID-19 may help explain the increased rates of cardiac and noncardiac mortality among TAVR patients, but there are several other factors to consider as well. Researchers explored nearly 11 years of STS/ACC registry data to learn more.

American Heart Association dedicates another $2M to COVID-19 research

“We were just blown away and so impressed to see this level of interest and commitment from the teams submitting such thorough proposals so quickly,” said AHA President Robert A. Harrington, MD.

Novartis launches FDA-approved study involving hydroxychloroquine, azithromycin, COVID-19 patients

Novartis is launching a new clinical trial to assess the effectiveness of treating hospitalized COVID-19 patients with hydroxychloroquine.

What high COVID-19 mortality among black patients tells us about CVD care in the US

The high mortality rates from COVID-19 among black patients and other racial/ethnic minorities put a much-needed spotlight on the “deep-rooted failures” of the U.S. healthcare system to improve care for cardiovascular disease (CVD), according to a new commentary.

First COVID-19 death in US caused by a ruptured heart

The first known death from COVID-19 in the United States was caused by a ventricular rupture.

Quest Diagnostics invites healthcare consumers to request their own COVID antibody tests

The company announced the service launch April 28, saying individuals who want the test can request it online—cost: $119—without referral from a doctor.

Society for Imaging Informatics in Medicine the latest to cancel its in-person conference

SIIM said the decision was influenced by both continued travel restrictions among its members and a desire to quell the spread of COVID-19.

Is a COVID showdown ahead between Google–Apple and governments?

Governments around the world have their own COVID contact-tracing apps already up and running—and several U.S. states have indicated they like their own solutions just fine.

5 notable quotes from COVID-19 physicians

Several physicians on the front lines of the battle against COVID-19 have taken to the pages of online and print publications to share their firsthand experiences.

COVID-19

PET imaging reveals long-term heart and lung damage from COVID-19

HHS, NIH announce new ‘universal’ vaccine standard for broad-spectrum protection

HHS sued over RFK’s $11B cuts to infectious disease control

Owner of home healthcare company gets 14 months for defrauding COVID programs

Deaths after TAVR are on the rise: Is the pandemic to blame or should cardiologists be concerned?